Clients in the Media Found 3 Results October 10, 2025 | MeiraGTx Lilly bags eye-catching retinal disease gene therapy from MeiraGTx in $475M deal, FierceBiotech March 13, 2025 | MeiraGTx Hologen AI commits up to $430M to help take MeiraGTx’s Parkinson’s gene therapy through phase 3 and beyond FierceBiotech February 21, 2025 | MeiraGTx MeiraGTx gene therapy allows 11 blind children to see as biotech eyes accelerated approval FierceBiotech
